“Public health is the science and art of preventing disease, prolonging life, and promoting health through the organized efforts and informed choices of society, organizations, public and private communities, and individuals.”
~ CEA Winslow
Disease Prevention
Early Detection
Precision Medicine
Multi-Omics Testing
Genetic Factors and Gene Expression
Next-Generation Therapies
Personalized Treatments
The translation process, from bench to bedside, plays a crucial role in improving patient outcomes. While other non-profits fund research, MADP focuses on translating years of research into clinical breakthroughs. Together, we are driving action forward to save lives.
MADP aggressively pursues breakthrough treatments, life-saving therapies, and cures for patients ~ delivering promises sooner rather than later.
We collaborate with medical research institutions, life science companies, and investment professionals to accelerate breakthroughs, access testing, and patient clinical trials – with a primary focus on cancer . (*WHO/CDC – Cancer is the second most common cause of death in the US, exceeded only by heart disease. Over 1.9 million new cancer cases are expected to be diagnosed.)
In the context of cancer, precision medicine is often referred to as precision oncology. Precision oncology is a form of personalized cancer treatment targeted to a patient’s exact cancer. It incorporates specific tumor biomarkers and genomics to identify the treatments most likely to benefit the patient, while avoiding those that are unlikely to be effective.
Only 5 to 10% of cancers are inherited. The majority of cancers are caused by genetic abnormalities or dysregulation which can be attributed to environmental factors, lifestyle, spontaneous genetic mutations, or genetic alterations.
MADP Circle of Hope ~ ‘ It is Important to Know Your Tumor Biomarkers’.
We work in close collaboration with physicians, hospital systems, and public health institutions to provide clinical education, evidence-informed resources, and implementation support.
Our providers are on the front lines helping patient’s battle chronic disease. Due to overload, it is difficult for clinicians to stay on top of the rapidly evolving scientific and clinical advancements. We ease the burden placed on our healthcare leaders and help them overcome these hurdles.
We prioritize value-based care by equipping providers with the latest advancements in early detection testing and precision diagnostics – helping providers identify the early drivers of non-communicable chronic diseases (NCDs). This enables earlier diagnoses, interventions, and improved long-term outcomes.
MADP Precision Public Health: Smarter Screening. Smarter Testing. Earlier Intervention.
Please join Dr. Chris Huff, Board-Certified Cardiologist and Cassandra Isley, CEO of MADP Alliance for Disease Prevention to learn more.
PCHP Podcast _ Advanced Biomarker Testing and the Future of Preventive Cardiology.
Chris Huff, MD, FACC, FSVM, RPVI, board-certified cardiologist at OhioHealth Heart and Premier Cardio Health and MADP Alliance for Disease Prevention CEO, Cassandra Isley, MT(ASCP) – discuss important biomarker tests for early detection of heart disease, the role of metabolic health, the role of the microbiome, and how both patients and physicians can use evidence-based strategies to stay ahead of cardiovascular disease.
We partner with mission-aligned organizations and nonprofits dedicated to advancing prevention, precision medicine, and value-based care. Together, our efforts are driving progress in early detection, smarter testing and screening, and proactive interventions that improve health outcomes while reducing system-wide burden.
Our partnership is a commitment towards prevention-focused models of care – supporting earlier identification of disease and a more sustainable use of healthcare resources.
As part of this shared mission, we invite you to explore the American Medical Association’s work on value-based care:_ What Is Value-Based Healthcare? – AMA 2025.
We have a seat at the table working directly with patient groups and community health outreach.
Early detection is KEY. Our unrelenting focus – helping every person advocate for their health, MADP provides clinical support resources and public health outreach programs for:
“Cancer prevention is not just about saving lives, it’s about preserving the future, protecting families, and ensuring a world where health thrives over hardship. Investing in prevention today means sparing countless tomorrows from the shadow of this devastating disease. Thank you MADP.” ~ Eleanor Hart
Through the MADP Precision Nutrition® | Food as Medicine Program, we collaborate with organizations to advance equitable access to healthy nutrition for low-income and food-insecure populations.
Together through our network of industry, community, and clinical partners, we advocate accessibility to healthy foods, provide nutritional education, and implement disease prevention strategies.
Together, we are committed to breaking down barriers and driving sustainable, positive health outcomes.
